Skip to content
10-Q

Quarterly Report

X4 Pharmaceuticals, Inc XFOR

0001501697-25-000043

← back to feed
Filed
Nov 5, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 87.44M sh
Shares Diluted Q3 2025 · Sep 30, 2025 43.27M sh
Shares Diluted Q3 2025 · Sep 30, 2025 19.24M sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 6.7M sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 6.69M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$70.09M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$97.91M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $69.63M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $55.7M
Stockholders Equity Q3 2025 · Sep 30, 2025 $61.62M
Stockholders Equity Q3 2025 · Jun 30, 2025 $3.97M
Stockholders Equity Q3 2025 · Mar 31, 2025 $22.94M
Stockholders Equity Q3 2025 · Dec 31, 2024 $22.15M
Stockholders Equity Q3 2025 · Sep 30, 2024 $59.62M
Stockholders Equity Q3 2025 · Jun 30, 2024 $94.45M
Stockholders Equity Q3 2025 · Mar 31, 2024 $1.04M
Stockholders Equity Q3 2025 · Dec 31, 2023 $51.1M
Current Liabilities Q3 2025 · Sep 30, 2025 $23.51M
Current Liabilities Q3 2025 · Dec 31, 2024 $32.88M
Total Liabilities Q3 2025 · Sep 30, 2025 $101.94M
Total Liabilities Q3 2025 · Dec 31, 2024 $124.3M
Current Assets Q3 2025 · Sep 30, 2025 $132.81M
Current Assets Q3 2025 · Dec 31, 2024 $112.18M
Total Assets Q3 2025 · Sep 30, 2025 $163.56M
Total Assets Q3 2025 · Dec 31, 2024 $146.45M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.69
Eps Diluted Q3 2025 · Sep 30, 2025 −$2.87
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$5.48
Eps Diluted restated Q3 2025 · Sep 30, 2024 $0.35
Eps Basic Q3 2025 · Sep 30, 2025 −$0.69
Eps Basic Q3 2025 · Sep 30, 2025 −$2.87
Eps Basic restated Q3 2025 · Sep 30, 2024 −$5.48
Eps Basic restated Q3 2025 · Sep 30, 2024 $0.35
Sga Expense Q3 2025 · Sep 30, 2025 $11.59M
Sga Expense Q3 2025 · Sep 30, 2025 $36.13M
Sga Expense Q3 2025 · Sep 30, 2024 $15.66M
Sga Expense Q3 2025 · Sep 30, 2024 $46.37M
Rd Expense Q3 2025 · Sep 30, 2025 $17.34M
Rd Expense Q3 2025 · Sep 30, 2025 $54.2M
Rd Expense Q3 2025 · Sep 30, 2024 $19.17M
Rd Expense Q3 2025 · Sep 30, 2024 $59.94M
Net Income Q3 2025 · Sep 30, 2025 −$29.82M
Net Income Q3 2025 · Sep 30, 2025 −$55.27M
Net Income Q3 2025 · Jun 30, 2025 −$25.74M
Net Income Q3 2025 · Mar 31, 2025 $282K
Net Income Q3 2025 · Sep 30, 2024 −$36.7M
Net Income Q3 2025 · Sep 30, 2024 $2.37M
Net Income Q3 2025 · Jun 30, 2024 $90.83M
Net Income Q3 2025 · Mar 31, 2024 −$51.77M
Operating Income Q3 2025 · Sep 30, 2025 −$27.51M
Operating Income Q3 2025 · Sep 30, 2025 −$63.18M
Operating Income Q3 2025 · Sep 30, 2024 −$34.5M
Operating Income Q3 2025 · Sep 30, 2024 −$686K
Cost Of Revenue Q3 2025 · Sep 30, 2025 $351K
Cost Of Revenue Q3 2025 · Sep 30, 2025 $5.39M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $227K
Cost Of Revenue Q3 2025 · Sep 30, 2024 $495K
Revenue Q3 2025 · Sep 30, 2025 $1.77M
Revenue Q3 2025 · Sep 30, 2025 $32.55M
Revenue Q3 2025 · Sep 30, 2024 $560K
Revenue Q3 2025 · Sep 30, 2024 $1.12M